Diagnostic confusion resulting from CD56 expression by cutaneous myeloid sarcoma

Myeloid sarcomas are tumor masses composed of aggregates of malignant myeloid precursors in extramedullary sites including the skin. We report a case of myeloid sarcoma in a patient who presented with an ear lobe mass and facial nerve paralysis. Expression of CD56 by the malignant cells led to an initial misdiagnosis as Merkel cell tumor. Comprehensive pathological evaluation confirmed the diagnosis of myeloid sarcoma with aberrant expression of CD56 and carrying the translocation t(8;21) (q22;q22). Aberrant antigen expression by cutaneous myeloid sarcomas can cause diagnostic confusion with other cutaneous neoplasms. This is especially relevant when myeloid sarcoma is the sole manifestation of acute myeloid leukemia.

[1]  C. Ross,et al.  TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis , 2007, Modern Pathology.

[2]  S. Pileri,et al.  Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients , 2007, Leukemia.

[3]  C. Massone,et al.  CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer , 2006, Journal of Clinical Pathology.

[4]  C. Meijer,et al.  CD 56 1 hematological neoplasms presenting in the skin : a retrospective analysis of 23 new cases and 130 cases from the literature , 2004 .

[5]  M. Ueda,et al.  Myeloid markers should be undertaken in cases of CD56 positivity to exclude granulocytic sarcoma , 2002, The British journal of dermatology.

[6]  P. Mahendra,et al.  Chloroma (aleukaemic leukaemia cutis) initially diagnosed as cutaneous lymphoma , 2002, Clinical and experimental dermatology.

[7]  P. Tai,et al.  Merkel Cell Carcinoma of the Skin , 2000, Journal of cutaneous medicine and surgery.

[8]  鈴木 律朗 CD7[+] and CD56[+] myeloid/natural killer cell precursor acute leukemia : a distinct hematolymphoid disease entity , 1998 .

[9]  K. Smith,et al.  Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. , 1997, Journal of the American Academy of Dermatology.

[10]  J. Chan,et al.  Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. , 1997, Blood.